Drug Profile
Amlodipine/losartan - Hanmi Pharmaceutical
Alternative Names: Amlozaar; Amosartan; ARB/CCB; Bicartial; Branta; CCB/ARB; Cozaar XQ; HCP 0605; Ildusartán; Losartan/amlodipine - Hanmi Pharmaceutical; Sardip; Tozam; UI-15AML055MTLatest Information Update: 01 Aug 2019
Price :
$50
*
At a glance
- Originator Hanmi Pharmaceutical
- Developer Hanmi Pharmaceutical; Merck Sharp & Dohme
- Class Antihypertensives; Dihydropyridines; Heart failure therapies; Imidazoles; Ischaemic heart disorder therapies; Small molecules; Tetrazoles
- Mechanism of Action Angiotensin type 1 receptor antagonists; Calcium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Hypertension